Results 171 to 180 of about 80,480 (249)

Risk factors for thrombotic events in Philadelphia chromosome-negative myeloproliferative neoplasms: a retrospective analysis of 336 cases. [PDF]

Front Oncol
Zhang L, Wang X, Yang M, Zi Y, Zhang Y, Guo Y, Lv G, Wu S, Huang Y.   +8 more
europepmc   +1 more source

Transformed to myelofibrosis is a risk factor for pulmonary hypertension in Philadelphia chromosome-negative myeloproliferative neoplasms. [PDF]

Ann Hematol
Suolitiken D, Han X, Feng C, Wang Y.
europepmc   +1 more source

[Philadelphia chromosome].

Postepy biochemii, 2003
Ireneusz, Majsterek, Janusz, Błasiak
openaire   +1 more source

Disseminated rhino-orbital-cerebral mucormycosis in Philadelphia chromosome-positive mixed phenotype acute leukemia: a case report and literature review. [PDF]

Front Med (Lausanne)
Zhou Y, He M, Zhang Q, Yao J, Wang Z, Chen B, Guo J, Gao F, Liu Z.   +8 more
europepmc   +1 more source

Poor prognostic implication of CDKN2 deletion in adult patients with Philadelphia chromosome-positive ALL. [PDF]

Blood Cancer J
Park SY, Kwag D, Jung J, Min GJ, Park SS, Park S, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Min CK, Cho SG, Kim Y, Kim M, Lee S, Yoon JH.   +16 more
europepmc   +1 more source

The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or Philadelphia chromosome-like acute lymphoblastic leukemia. [PDF]

Cancer Med
Wu X, Lu S, Zhang X, Yang Z, Sun A, Wu D, Zhou H, Miao M.   +7 more
europepmc   +1 more source

P2RX1 promotes mitochondrial apoptosis via calcium/CaM KII-mediated suppression of PI3K/Akt signaling in Philadelphia chromosome-positive acute lymphoblastic leukemia. [PDF]

Front Pediatr
Li XB, Ren Q, Ye XM, Li JL, Feng LG.
europepmc   +1 more source

Rapid development of Philadelphia chromosome-negative AML in a CML patient with sustained major molecular response to tyrosine kinase inhibitor therapy. [PDF]

Leuk Res Rep
Liu H, Sun Y, Li L, Zhang Y, Zhou Y, Zeng P, Yue L.   +6 more
europepmc   +1 more source

Targeting senescent stemlike subpopulations in Philadelphia chromosome-like acute lymphoblastic leukemia.

Blood
Ding YY, Sussman JH, Madden K, Loftus JP, Chen RK, Falkenstein CD, Bárcenas López DA, Hottman DA, Mathier B, Yu W, Xu J, Chen C, Chen CH, He B, Bandyopadhyay S, Zhang Z, Lee D, Wang H, Peng J, Dang CV, Tan K, Tasian SK.   +21 more
europepmc   +1 more source

[Safety of blinatumomab combined with dasatinib in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Zheng FY, Ding MM, Lu AD, Jia YP, Zeng HM, Zhang LP.   +5 more
europepmc   +1 more source